Jump to content

List of countries by antidepressant consumption

From Wikipedia, the free encyclopedia


This is a list of countries by antidepressant consumption according to data published by the OECD.

OECD list

[edit]

The source for the data below is the OECD Health Statistics 2018, released by the OECD in June 2018 and updated on 8 November 2018.[1]

The unit of measurement used by the OECD is defined daily dose (DDD), defined as "the assumed average maintenance dose per day for a drug used on its main indication in adults".[2] The sources used by the OECD are primarily national health authorities.[2] Definitions, sources and methodology per country is explained further in a document available on the OECD website.[2] The OECD have not included the United States in these reviews, but if added the country would have the highest or second-highest rate.[3]

Country Defined daily dosage
per 1,000 inhabitants per day
Year Data include drugs
dispensed in hospitals
Data include non-
reimbursed drugs
Data include
OTC drugs
Notes
 Iceland 141.4 2017 Yes Yes Yes
 Australia 106.7 2016 No Yes No
 Portugal 103.6 2017 No Yes[note 1] Yes[note 2]
 United Kingdom 100.1 2016 No No
 Canada 99.6 2017 No No See note[note 3] [note 4]
 Sweden 96.8 2017 Yes Yes Yes[note 5]
 Belgium 79.0 2016 No No No
 Denmark 77.0 2015 Yes Yes Yes
 Spain 75.5 2016 No No No
 New Zealand 72.8 2014 [note 6]
 Finland 67.6 2016 Yes[note 7] Yes Yes
 Austria 60.5 2016 No[note 8] See note[note 9] No
 Slovenia 58.6 2016 No See note[note 10] See note[note 11]
 Norway 57.1 2017 Yes Yes Yes
 Czech Republic 57.1 2016 Yes Yes Yes
 Germany 56.5 2016 No See note[note 12] No
 Luxembourg 52.7 2017 No No No [note 4]
 France 49.8 2009 Yes[note 13] Yes Yes
 Israel 49.2 2017 No No No
 Greece 48.1 2015 No No No [note 6]
 Netherlands 46.1 2016 No No No
 Chile 41.4 2017 Yes Yes
 Turkey 41.0 2016 No Yes See note[note 14]
 Italy 40.3 2017 No No [note 15]
 Slovakia 38.9 2016 Yes Yes Yes
 Hungary 28.8 2017 No No No
 Estonia 28.8 2017 Yes Yes Yes
 South Korea 19.9 2016 Yes Yes Yes
 Latvia 13.3 2016

See also

[edit]

Notes

[edit]
  1. ^ Data include both reimbursed and non-reimbursed products.
  2. ^ Yes, but only OTC products sold in pharmacies.
  3. ^ Generally, claims for OTC drugs are not reimbursed, but OTC drugs are not explicitly excluded.
  4. ^ a b Provisional value.
  5. ^ Data include OTC drugs both from pharmacies and from other retailers.
  6. ^ a b Difference in methodology.
  7. ^ Data are based on wholesale of pharmaceuticals.
  8. ^ Drug consumption in hospitals and in hospital ambulances is excluded.
  9. ^ Data cover only drugs reimbursed by the sickness funds within the statutory health insurance.
  10. ^ Data include all medicines with a medical prescription – compulsory health insurance, regardless of the reimbursement.
  11. ^ Only OTC drugs with a medical prescription.
  12. ^ Data contain exclusively the drug consumption debited to the statutory health insurance (i.e. drugs reimbursed by German Statutory Health Insurance).
  13. ^ Data include drug consumption both in hospitals and in pharmacies.
  14. ^ Data include drugs dispensed in pharmacies and non-reimbursed drugs.
  15. ^ Estimated value.

References

[edit]
  1. ^ "OECD Health Statistics 2018". OECD. 28 June 2018. Retrieved 10 May 2019.
  2. ^ a b c "OECD Health Statistics 2018: Definitions, Sources and Methods". OECD. June 2018. Retrieved 10 May 2019.
  3. ^ Gould, S.; L.F. Friedman (4 February 2016). "Something startling is going on with antidepressant use around the world". Business Insider. Retrieved 18 July 2020.
[edit]